Targeting the stem cell niche is an emerging regenerative medicine strategy.
In vivo regenerative medicine merges stem cell biology and biomaterials science.
A number of recent studies highlight the promise of in vivo regenerative medicine.
Endogenous repair advances require fundamental research and computational modeling.